BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TPR, P12270, 7175
26 results:

  • 1. brain tumour classification using MRI images based on lenet with golden teacher learning optimization.
    Aluri S; Imambi SS
    Network; 2024 Feb; 35(1):27-54. PubMed ID: 37947040
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of the accuracy of Monte Carlo and Ray Tracing dose calculation algorithms for multiple target brain treatments on CyberKnife.
    Mukwada G; Skorska M; Rowshanfarzad P; Ebert MA
    Phys Eng Sci Med; 2023 Dec; 46(4):1477-1487. PubMed ID: 37552365
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stereotactic radiosurgery for tumors of the pineal region: A single-center experience.
    Zeynal M; Karaaslan B; Dağli Ö; Börcek A; Kurt G; Kadioğlu HH; Emmez ÖH
    Medicine (Baltimore); 2023 Jul; 102(27):e34005. PubMed ID: 37417623
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging for Language Mapping in brain Tumor Surgery: Validation With Direct Cortical Stimulation and Cortico-Cortical Evoked Potential.
    Kang KM; Kim KM; Kim IS; Kim JH; Kang H; Ji SY; Dho YS; Oh H; Park HP; Seo HG; Kim SM; Choi SH; Park CK
    Korean J Radiol; 2023 Jun; 24(6):553-563. PubMed ID: 37271209
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
    Li Y; Feng Y; Luo F; Peng G; Li Y
    Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Automated segmentation of craniopharyngioma on MR images using U-Net-based deep convolutional neural network.
    Chen C; Zhang T; Teng Y; Yu Y; Shu X; Zhang L; Zhao F; Xu J
    Eur Radiol; 2023 Apr; 33(4):2665-2675. PubMed ID: 36396792
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel
    Deland L; Keane S; Bontell TO; Fagman H; Sjögren H; Lind AE; Carén H; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
    Cancer Genomics Proteomics; 2022; 19(6):711-726. PubMed ID: 36316040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.
    Bahcall M; Paweletz CP; Kuang Y; Taus LJ; Sim T; Kim ND; Dholakia KH; Lau CJ; Gokhale PC; Chopade PR; Hong F; Wei Z; Köhler J; Kirschmeier PT; Guo J; Guo S; Wang S; Jänne PA
    Mol Cancer Ther; 2022 Feb; 21(2):322-335. PubMed ID: 34789563
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
    Arakawa Y; Sasaki K; Mineharu Y; Uto M; Mizowaki T; Mizusawa J; Sekino Y; Ono T; Aoyama H; Satomi K; Ichimura K; Kinoshita M; Ohno M; Ito Y; Nishikawa R; Fukuda H; Nishimura Y; Narita Y;
    BMC Cancer; 2021 Oct; 21(1):1105. PubMed ID: 34654402
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The effectiveness of generic emails versus a remote knowledge broker to integrate mood management into a smoking cessation programme in team-based primary care: a cluster randomised trial.
    Minian N; Ahad S; Ivanova A; Veldhuizen S; Zawertailo L; Ravindran A; de Oliveira C; Baliunas D; Mulder C; Bolbocean C; Selby P
    Implement Sci; 2021 Mar; 16(1):30. PubMed ID: 33743777
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. DeepHPV: a deep learning model to predict human papillomavirus integration sites.
    Tian R; Zhou P; Li M; Tan J; Cui Z; Xu W; Wei J; Zhu J; Jin Z; Cao C; Fan W; Xie W; Huang Z; Xie H; You Z; Niu G; Wu C; Guo X; Weng X; Tian X; Yu F; Yu Z; Liang J; Hu Z
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33059369
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Quality assurance of Cyberknife robotic stereotactic radiosurgery using an angularly independent silicon detector.
    Alhujaili SF; Biasi G; Alzorkany F; Grogan G; Al Kafi MA; Lane J; Hug B; Aldosari AH; Alshaikh S; Farzad PR; Ebert MA; Moftah B; Rosenfeld AB; Petasecca M
    J Appl Clin Med Phys; 2019 Jan; 20(1):76-88. PubMed ID: 30565856
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
    Xu Y; Wang K; Yu Q
    Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.
    Bolger GB; Bizzi MF; Pinheiro SV; Trivellin G; Smoot L; Accavitti MA; Korbonits M; Ribeiro-Oliveira A
    Endocr Relat Cancer; 2016 May; 23(5):419-31. PubMed ID: 27267386
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
    Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
    J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Structure of the tpr domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the tpr domain of AIP is sufficient for pituitary adenoma predisposition.
    Morgan RM; Hernández-Ramírez LC; Trivellin G; Zhou L; Roe SM; Korbonits M; Prodromou C
    PLoS One; 2012; 7(12):e53339. PubMed ID: 23300914
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
    Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
    Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. AIP and its interacting partners.
    Trivellin G; Korbonits M
    J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.